Diffusion-weighted MRI precisely predicts telomerase reverse transcriptase promoter mutation status in World Health Organization grade IV gliomas using a residual convolutional neural network.

Abstract

Authors

• Congman Hu
  Department of Neurosurgery, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
• Ke Fang
  College of Information Science and Electronic Engineering, Zhejiang University, Hangzhou 310020, China.
• Quan Du
  Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
• Jiarui Chen
  Department of Computer and Information Science, Faculty of Science and Technology, University of Macau, Macau, China.
• Lin Wang
  Department of Engineering Mechanics, Tsinghua University, Beijing 100084, China.
• Jianmin Zhang
  Department of Neurosurgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
• Ruiliang Bai
  Department of Physical Medicine and Rehabilitation of the Affiliated Sir Run Run Shaw Hospital and Interdisciplinary Institute of Neuroscience and Technology, School of Medicine, Zhejiang University, Hangzhou 310020, China.
• Yongjie Wang
  Department of Epidemiology and Medical Statistics School of Public Health, Guangdong Medical University, Dongguan, Guangdong, China.

Keywords

External Resources